Fujifilm initiates phase I trial of anti-cancer agent FF-10502 in US to treat …

Fujifilm initiates phase I trial of anti-cancer agent FF-10502 in US to treat …

FUJIFILM Corporation has begun a phase I clinical trial of its anti-cancer agent FF-10502 in the United States on patients with solid tumours, including pancreatic cancer. The trial will be expanded in facilities including at the University of Texas MD

(Visited 3 times, 1 visits today)
3
Like
Save

Comments

Comments are disabled for this post.